This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Hospital del Mar Medical Research Institute (IMIM) | |
|---|---|
| Name | Hospital del Mar Medical Research Institute (IMIM) |
| Established | 1995 |
| Location | Barcelona, Catalonia, Spain |
| Affiliations | Hospital del Mar, Universitat Pompeu Fabra |
Hospital del Mar Medical Research Institute (IMIM) IMIM is a biomedical research institute based in Barcelona closely linked to Hospital del Mar and regional health and university institutions. The institute conducts basic, clinical, and translational research with emphasis on cardiovascular, oncological, neuroscientific, epidemiological, and personalized medicine domains. IMIM engages with local, national, and international organizations to translate discoveries into health interventions and policy.
IMIM traces its institutional roots to the clinical services of Hospital del Mar and the research ambitions of Universitat Pompeu Fabra, integrating investigators from hospitals such as Hospital Clínic de Barcelona, Vall d'Hebron University Hospital, and research centers including Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona Supercomputing Center, and Centre de Regulació Genòmica. Early collaborations involved projects with Instituto de Salud Carlos III, European Molecular Biology Laboratory, European Research Council, and networks connected to World Health Organization initiatives. Over the decades IMIM researchers have participated in consortia with Institut Català d'Oncologia, Barcelona Institute for Global Health, Institut de Recerca Biomèdica de Barcelona (IRB Barcelona), and industrial partners such as Grifols. The institute's historical trajectory includes funding and program links to Horizon 2020, FP7, Wellcome Trust, Bill & Melinda Gates Foundation, and national programs tied to Ministerio de Ciencia e Innovación.
IMIM operates as an independent research center associated with Hospital del Mar and academically linked to Universitat Pompeu Fabra, with governance structures influenced by statutory frameworks such as those of Generalitat de Catalunya and Spanish research law under Ministerio de Sanidad. Its governance involves boards and scientific advisory committees drawn from institutions like Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Salud Carlos III, Catalan Health Service (Servei Català de la Salut), and international advisors from Karolinska Institutet, Imperial College London, Harvard Medical School, and Max Planck Society. Management coordinates with funding agencies including European Commission, Fundación Bancaria La Caixa, Carlos III Health Institute, and philanthropic entities like Fundación Ramón Areces. IMIM’s internal structure includes research groups led by principal investigators modeled after organizational practices at Institut Pasteur and Broad Institute.
IMIM hosts programs spanning cardiovascular research with links to European Society of Cardiology, oncology programs aligned with European Society for Medical Oncology, neuroscience initiatives connected to Human Brain Project, and public health and epidemiology projects cooperating with European Centre for Disease Prevention and Control and Centers for Disease Control and Prevention. Other areas include genomics and bioinformatics related to Genomics England, 100,000 Genomes Project, and computational biology akin to efforts at European Bioinformatics Institute. IMIM scientists pursue precision medicine projects informed by consortia such as International Cancer Genome Consortium, pharmacology collaborations referencing European Medicines Agency, and aging research with partners like Max Planck Institute for Biology of Ageing. Programs emphasize translational pipelines similar to Translational Genomics Research Institute models, and methodological links to Cochrane Collaboration, STROBE initiatives, and clinical trial networks such as ClinicalTrials.gov registries.
Clinical research at IMIM integrates with clinical services at Hospital del Mar and multi-center trials coordinated with hospitals including Hospital Universitari Vall d'Hebron, Hospital Sant Pau, and international centers such as Mayo Clinic and Johns Hopkins Hospital. Translational activities leverage collaborations with biobanking initiatives like BBMRI-ERIC and registries connected to European Cancer Registry (EUREG), applying biomarkers, imaging, and omics technologies akin to workflows at Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. IMIM investigators contribute to guideline development with professional societies such as European Society of Cardiology, European Respiratory Society, and European Society for Paediatric Research, and participate in randomized controlled trials following standards promoted by CONSORT and data-sharing platforms influenced by Global Alliance for Genomics and Health.
IMIM provides doctoral and postdoctoral training in cooperation with Universitat Pompeu Fabra, offering PhD programs coordinated with graduate schools like Barcelona Graduate School of Economics and professional development tied to continuing education frameworks of European Higher Education Area. Training activities include clinical fellowships with Hospital del Mar, postdoctoral exchanges with Karolinska Institutet and University of Oxford, and short courses modeled after programs at Cold Spring Harbor Laboratory and EMBO. IMIM supports workshops and summer schools in collaboration with Institute for Research in Biomedicine (IRB), scholarships from La Caixa Foundation, and mobility funded by Marie Skłodowska-Curie Actions.
IMIM maintains partnerships across academia, industry, and public institutions, collaborating with Universitat Pompeu Fabra, Hospital del Mar, IDIBAPS, IRB Barcelona, Barcelona Supercomputing Center, Grifols, Roche, Novartis, GlaxoSmithKline, and non-profits like World Health Organization and Médecins Sans Frontières. International consortia include projects with European Commission Horizon Europe, European Research Council, Wellcome Trust, Bill & Melinda Gates Foundation, and networks such as ELIXIR and EATRIS. Regional partnerships involve Agència de Qualitat i Avaluació Sanitàries de Catalunya and municipal collaborations with Ajuntament de Barcelona.
IMIM’s infrastructure comprises laboratories, clinical research units, biobanks, and core facilities for genomics, proteomics, and imaging comparable to platforms at European Molecular Biology Laboratory and European Synchrotron Radiation Facility. The institute uses computing resources linked to Barcelona Supercomputing Center and data platforms interoperable with ELIXIR and BBMRI-ERIC. Clinical trial units follow standards of ICH-GCP and maintain accredited laboratories with quality frameworks similar to European Medicines Agency guidelines. Shared facilities enable multidisciplinary projects with neighboring centers such as Institut de Recerca Vall d'Hebron and Hospital Clínic de Barcelona.
Category:Medical research institutes in Spain